(redirected from Pre-exposure prophylaxis)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Pre-exposure prophylaxis: Truvada, Post-exposure prophylaxis
See: deterrence
References in periodicals archive ?
Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with men.
Southern African guidelines for the safe use of pre-exposure prophylaxis in men who have sex with men who are at risk for HIV infection.
Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site.
The need for guidance on the use of antiretrovirals by HIV-negative people to prevent infection - pre-exposure prophylaxis (PrEP) - will be addressed in a 'rapid advice' document for release in mid-2012.
Pre-exposure prophylaxis (PrEP) is the taking of a pharmaceutical agent prior to an exposure to prevent an outcome (e.
Detailed safety of tenofovir for pre-exposure prophylaxis will need confirmation from longer term follow-up of larger numbers of exposed children," they added.
Following is what the Truvada packaging and printed drug warning inserts now state regarding use of the drug for pre-exposure prophylaxis (PrEP) for HIV prevention:
In the current economic climate, these methods, which are still in development, including pre-exposure prophylaxis (PREP), are facing constraints to complete the requisite safety and efficacy trials and regulatory processes.
These findings are clear evidence that this new HIV prevention strategy, called pre-exposure prophylaxis (or PrEP), substantially reduces HIV infection risk.
At the same time, funding for both microbicides and pre-exposure prophylaxis (PrEP) increased by 8% and 13%, respectively, in 2008.
Like Adam, many gay men around the country are opting to forgo the standard defense against HIV--a condom-in favor of a highly controversial and thus far unproven method of protection known as pre-exposure prophylaxis, or PREP.
WASHINGTON -- AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS nonprofit medical provider, today reaffirmed its opposition to the Food and Drug Administration's (FDA) approval of Gilead Sciences ' Truvada for use as Pre-Exposure Prophylaxis (PrEP) to prevent transmission of HIV.